Article
Serum cytochrome c indicates <i>in vivo</i> apoptosis and can serve as a prognostic marker during cancer therapy
30 Mar 2005
Abstract excerpt
Despite significant progress in cancer therapy, the outcome of the treatment is often unfavorable. Better treatment monitoring would not only allow an individual more effective, patient-adjusted therapy, but also it would eliminate some of the side effects. Using a cytochrome c ELISA that was modified to increase sensitivity, we demonstrate that serum cytochrome c is a sensitive apoptotic marker in vivo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
